Fast Five Quiz: Exocrine Pancreatic Insufficiency Management

Romesh Khardori, MD, PhD


March 08, 2021

The results of a prospective, longitudinal cohort study suggest that EPI is an independent risk factor for cardiovascular events in patients with CP. The incidence rate ratio for cardiovascular events in patients with EPI compared with those without the condition was 3.67.

A study examining the use of endoscopic therapy in patients with CP determined that this therapy is most useful in patients with pancreatic duct stones and dilation and should be used as first-line treatment for these patients; however, it cannot be recommended for all patients with CP.

Toskes and colleagues determined that CP patients with EPI may benefit from a low dose of pancrelipase whereas a high dose might be appropriate for patients with more severe EPI.

Learn more about PERT.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.